NK cells (derived from donor's CD34+ precursors) that express KIRs, mismatched with their HLA ligands in the donor versus recipient direction, clear leukemia blasts residual after the conditioning regimen, thus preventing leukemia relapses. Here, CD34 is linked to leukemia.